Literature DB >> 21691024

Psychological and social adjustment to blindness: understanding from two groups of blind people in Ilorin, Nigeria.

Mosunmola F Tunde-Ayinmode1, Tanimola M Akande, Dupe S Ademola-Popoola.   

Abstract

BACKGROUND: Blindness can cause psychosocial distress leading to maladjustment if not mitigated. Maladjustment is a secondary burden that further reduces quality of life of the blind. Adjustment is often personalized and depends on nature and quality of prevailing psychosocial support and rehabilitation opportunities. This study was aimed at identifying the pattern of psychosocial adjustment in a group of relatively secluded and under-reached totally blind people in Ilorin, thus sensitizing eye doctors to psychosocial morbidity and care in the blind.
MATERIALS AND METHODS: A cross-sectional descriptive study using 20-item Self-Reporting Questionnaire (SRQ) and a pro forma designed by the authors to assess the psychosocial problems and risk factors in some blind people in Ilorin metropolis. RESULT: The study revealed that most of the blind people were reasonably adjusted in key areas of social interaction, marriage, and family. Majority were considered to be poorly adjusted in the areas of education, vocational training, employment, and mobility. Many were also considered to be psychologically maladjusted based on the high rate of probable psychological disorder of 51%, as determined by SRQ. Factors identified as risk factors of probable psychological disorder were poor educational background and the presence of another medical disorder.
CONCLUSION: Most of the blind had no access to formal education or rehabilitation system, which may have contributed to their maladjustment in the domains identified. Although their prevailing psychosocial situation would have been better prevented yet, real opportunity still exists to help this group of people in the area of social and physical rehabilitation, meeting medical needs, preventive psychiatry, preventive ophthalmology, and community health. This will require the joint efforts of medical community, government and nongovernment organizations to provide the framework for delivery of these services directly to the communities.

Entities:  

Mesh:

Year:  2011        PMID: 21691024     DOI: 10.4103/1596-3519.82073

Source DB:  PubMed          Journal:  Ann Afr Med        ISSN: 0975-5764


  6 in total

1.  Burst Out of the Dead Land by the Help of Spirituality: A Case Study of Living with Blindness and Cancer.

Authors:  Seyed Hamid Seyed Bagheri; Mahlagha Dehghan; Seyyed Hamidreza Alavi; Sedigheh Iranmanesh; Hadi Khoshab
Journal:  J Relig Health       Date:  2017-06

2.  Vision loss and psychological distress among Ethiopians adults: a comparative cross-sectional study.

Authors:  Aemero Abateneh; Markos Tesfaye; Sisay Bekele; Yeshigeta Gelaw
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

3.  So let me find my way, whatever it will cost me, rather than leaving myself in darkness: experiences of glaucoma in Nigeria.

Authors:  Fatima Kyari; Clare I Chandler; Martha Martin; Clare E Gilbert
Journal:  Glob Health Action       Date:  2016-12-06       Impact factor: 2.640

4.  Adjustment to acquired vision loss in adults presenting for visual disability certification.

Authors:  Aditya Nakade; Jolly Rohatgi; Manjeet S Bhatia; Upreet Dhaliwal
Journal:  Indian J Ophthalmol       Date:  2017-03       Impact factor: 1.848

5.  Visual impairment and psychological distress among adults attending the University of Gondar tertiary eye care and training center, Northwest Ethiopia: A comparative cross-sectional study.

Authors:  Minychil Bantihun Munaw; Melkamu Temeselew Tegegn
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

6.  Integrating stages of change models to cast new vision on interventions to improve global retinoblastoma and childhood cancer outcomes.

Authors:  Meaghann S Weaver; Christina L Heminger; Catherine G Lam
Journal:  BMC Public Health       Date:  2014-09-11       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.